Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Diaverum Sweden AB
AB
Active
Org 5562092790
Hyllie Boulevard 53, 215 37
Malmö
Medical specialists activities
· NACE 8622
Est. 1981
58 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Diaverum Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KJ
Karin Jeanette Roosberg
Chief Auditor
Chief Auditor
2024
Former (7)
CS
Curth Sven Ola Carlsson
External Signatory
External Signatory
2022 – 2023
JP
Jenny Pernilla Winberg
External Signatory
External Signatory
2022 – 2022
RM
Ruth Madeleine Klingryd
Chief Executive Officer
Chief Executive Officer
2021 – 2022
MI
Magdalena Ivanovska
External Signatory
External Signatory
2022 – 2022
JE
Jonas Ebbe Nihlberg
Chief Auditor
Chief Auditor
2021 – 2024
AM
Annica Maria Rosenborg
Chief Executive Officer
Chief Executive Officer
2022 – 2023
MA
Magnus Anders Olof Sjöholm
External Signatory
External Signatory
2021 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
ZS
Zisimos Sotiriou
Chairman
2025
SL
Sofia Louise Sellman Sundin
Board of Directors
2025
PM
Petra Margareta Mälarholm
Board of Directors
2025
Former (10)
ZV
Zoltán Vilmos Szepesi
Board of Directors
2025 – 2025
BM
Björn Martin Brixer
Board of Directors
2024 – 2025
JE
James Edward Sibley
Board of Directors
2023 – 2024
CR
Carl Rasmus Isak Engstrand
Board of Directors
2025 – 2025
HJ
Hasan Jasem,Naser Mohamed AlNowais
Chairman
2023 – 2024
SR
Simon Robert Ottosson
Chairman
2025 – 2025
HC
Hans Carl-Anders Abrahamsson
Chairman
2025 – 2025
AE
Anna Emelie Maria Lönnblad
Board of Directors
2025 – 2025
AK
Andreas Klas Anton Fagher
Board of Directors
2025 – 2025
DM
Dimitrios Moulavasilis
Chairman
2024 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Diaverum Group AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Diaverum Sweden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network